News

Discovered by Otsuka Pharma, OPA-6566 is currently under development by Otsuka Pharma for the treatment of glaucoma, in the US. As per the agreement, Otsuka Pharma will allow

As per the agreement, Proteros is expected to deploy its integrated Lead Discovery approach that interlinks structural biology, screening of a tailor-made in-house compound and fragment library, compound

Pfizer said that the discontinuation resulted from a scheduled interim analysis by an independent Data Monitoring Committee (DMC) which found that the combination of sunitinib with prednisone was

Under the partnership, Webmedx will fully integrate NLPI’s advanced natural language processing (NLP) software into their QualityAnalytics solution thereby expanding customers’ ability to mine discrete, structured data from

Centocor has submitted the sBLA seeking to expand the Simponi (golimumab) physician label to include inhibiting the progression of structural damage, inducing major clinical response (MCR) and maintenance

With the new software in place, Catalent will deliver media enhanced packing solutions to its clients that will instantly connect consumers to network services from printed packaging, inserts,

Most recently, Johnson worked as the president and CEO of Matrixx Initiatives. Prior to that, Johnson also has served as vice president, Commercial Development, for Perrigo Company and

Biocon and CIM have collaborated for almost a decade on an integrated program to manufacture and clinically evaluate recombinant proteins with the aim of building a portfolio based

ebrary claimed that it provides e-books and digital content services, from research and development to manufacturing and distribution, to marketing and sales, that can help pharmaceutical companies increase